CRIS Current Research Information System

GALLINELLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.325
NA - Nord America 7.766
EU - Europa 5.914
AF - Africa 463
SA - Sud America 437
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 22.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.662
VN - Vietnam 2.363
CN - Cina 2.302
SG - Singapore 1.982
IT - Italia 1.366
GB - Regno Unito 1.357
DE - Germania 670
HK - Hong Kong 538
SE - Svezia 495
FR - Francia 410
IN - India 388
UA - Ucraina 369
RU - Federazione Russa 322
BR - Brasile 296
IE - Irlanda 205
KR - Corea 182
JP - Giappone 154
CH - Svizzera 137
ZA - Sudafrica 128
EE - Estonia 109
NL - Olanda 106
FI - Finlandia 92
CI - Costa d'Avorio 87
TG - Togo 85
AR - Argentina 82
BG - Bulgaria 73
SC - Seychelles 59
CA - Canada 58
IQ - Iraq 48
TH - Thailandia 44
JO - Giordania 41
NG - Nigeria 41
IR - Iran 39
AT - Austria 38
ID - Indonesia 37
BE - Belgio 34
PH - Filippine 32
PL - Polonia 32
PK - Pakistan 31
MX - Messico 28
ES - Italia 27
TW - Taiwan 27
BD - Bangladesh 21
TR - Turchia 19
SA - Arabia Saudita 18
CO - Colombia 14
KE - Kenya 13
RO - Romania 11
UZ - Uzbekistan 11
EC - Ecuador 10
EG - Egitto 10
GR - Grecia 10
LB - Libano 10
CZ - Repubblica Ceca 9
LT - Lituania 9
AU - Australia 8
CL - Cile 8
CM - Camerun 8
DO - Repubblica Dominicana 8
PE - Perù 8
VE - Venezuela 8
MY - Malesia 7
HR - Croazia 6
MA - Marocco 6
OM - Oman 6
PY - Paraguay 6
TN - Tunisia 6
AZ - Azerbaigian 5
CY - Cipro 4
DZ - Algeria 4
HU - Ungheria 4
IL - Israele 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
LV - Lettonia 3
TZ - Tanzania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
KH - Cambogia 2
KZ - Kazakistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TD - Ciad 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CV - Capo Verde 1
DJ - Gibuti 1
Totale 22.905
Salva come PNG Salva come JPEG
Città #
Singapore 1.286
Southend 1.166
Ashburn 869
Fairfield 673
Chandler 589
Dong Ket 514
Hong Kong 504
Ho Chi Minh City 470
Hefei 426
San Jose 408
Hanoi 397
Seattle 340
Wilmington 325
Woodbridge 318
Princeton 277
Bologna 276
Houston 254
Dallas 248
Jacksonville 246
Ann Arbor 231
Cambridge 226
Beijing 218
Santa Clara 208
Dublin 204
Boardman 177
Seoul 161
Lauterbourg 146
Tokyo 134
Padova 129
Westminster 127
Bern 121
Nanjing 120
Los Angeles 115
Milan 104
Berlin 99
New York 97
Abidjan 87
Lomé 85
Helsinki 78
Buffalo 76
Sofia 72
Medford 70
Jinan 69
Council Bluffs 64
Haiphong 64
Saint Petersburg 63
Shenyang 63
Changsha 52
Shanghai 52
Da Nang 49
Zhengzhou 48
Tianjin 47
Hebei 46
Mülheim 46
Bengaluru 44
Redondo Beach 43
Amman 41
Parma 40
Nanchang 39
Abeokuta 37
San Diego 37
Florence 36
Buenos Aires 34
Rome 34
Guangzhou 33
Frankfurt am Main 32
Bremen 31
Brussels 31
Redwood City 31
Fremont 28
Hangzhou 28
Mahé 27
São Paulo 27
Biên Hòa 26
Jiaxing 25
Dearborn 24
London 24
Toronto 24
Verona 23
Yubileyny 23
Des Moines 22
Pune 22
Hải Dương 21
Ningbo 21
Phoenix 21
Vienna 21
Bangkok 20
Olalla 20
Taizhou 20
Warsaw 20
Johannesburg 18
Paris 18
Shenzhen 18
Modena 17
Thái Nguyên 17
Munich 16
Shijiazhuang 16
Turin 16
Wuhan 16
Bắc Ninh 15
Totale 14.531
Salva come PNG Salva come JPEG
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 324
Antiviral activity of brincidofovir on parvovirus B19 286
Restriction Factors expression decreases in HIV-1 patients after cART 269
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 248
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 245
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 237
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 232
No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions 222
Antiviral effect of cidofovir on parvovirus B19 replication 220
Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity 213
Advances in the development of antiviral strategies against parvovirus B19 211
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 209
The clinical use of parvovirus B19 assays: recent advances 207
Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin 207
A Parvovirus B19 synthetic genome: sequence features and functional competence 201
Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19 201
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 197
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 197
A Functional Minigenome of Parvovirus B19 197
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 194
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
A portable Microfluidic Device Based on Chemiluminescence Contact Imaging for detecting Parvovirus B19 in serum samples 191
Antiviral effect of Hydroxyurea on B19V replication 191
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 187
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 186
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 186
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 184
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 183
A proteomic approach to the analysis of B19 capsid proteins 183
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 180
Detection of viral DNA by isothermal NASBA amplification and chemiluminescence gene probe hybridization assay in a microfluidic cartridge 179
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 178
Mesenchymal stem cells are susceptible but non-permissive to B19V replication 178
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 177
Parvoviridae 177
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 176
Analisi della competenza funzionale di cloni genomici di parvovirus B19 175
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 175
Parvovirus B19 Achievements and Challenges 175
On-chip LAMP-BART reaction for viral DNA real-time bioluminescence detection 175
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 173
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 172
Recurrent erythema in patients with long-term parvovirus B19 infection 172
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 171
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells 169
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication 168
A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells 168
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells 165
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 164
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 163
Parvovirus B19 DNA detection in serum samples employing a microfluidic device based on chemiluminescence contact imaging. 163
Simian parvovirus infection: a potential zoonosis 161
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 161
Parvovirus B19-derived fetal complications following gestational infection. 161
Analysis at single cell level of parvovirus B19 expression process by chemiluminescent microscope imaging assays 161
Back from the past: Parvovirus B19 Genotype III DNA in the mummies of the Hermit Poor Clares of Fara in Sabina, Italy 160
Avermectins Inhibit Replication of Parvovirus B19 by Disrupting the Interaction Between Importin α and Non-Structural Protein 1 160
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 160
Analysis of the functional competence of genomic clones of Parvovirus B19 159
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells 157
Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells 157
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 155
How does parvovirus B19 DNA achieve lifelong persistence in human cells? 155
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 154
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 153
Portable chemiluminescence multiplex biosensor for quantitative detection of three B19 DNA genotypes 153
Parvovirus B19 in Rheumatic Diseases 152
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 152
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 152
Evidence of human bocavirus viremia in healthy blood donors. 151
Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells 151
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 150
Preliminary bioinformatic evaluation via Snakemake pipeline applied to 17th-18th century mummified specimens 149
A loop-mediated isothermal amplification (LAMP) assay to detect parvovirus B19 DNA in clinical samples 149
Microfluidic cartridge with integrated array of amorphous silicon photosensors for chemiluminescence detection of viral DNA 149
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 148
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 148
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2 147
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 147
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 147
Placental endothelial cells can be productively infected by Parvovirus B19 147
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays 142
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 141
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 140
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 140
Analysis on Parvovirus B19 life cycle at single cell level by chemiluminescent imaging assays 139
Tecniche di amplificazione real-time nella determinazione della carica virale: parvovirus B19 e papillomavirus umani 138
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones 137
Implicazioni nella progressione della patologia cervicale 135
Gastrointestinal lesions in parvovirus B19 infection 133
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 132
Reassembling in vitro the niche of Parvovirus B19 infection: a stem cell co-culture model 131
Antiviral effect of Cidofovir on B19V replication 131
Single-cell chemiluminescence imaging of parvovirus B19 life cycle 130
Inhibition of Parvovirus B19 replication by Cidofovir in extendedly exposed erythroid progenitor cells 129
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 128
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: Increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. 128
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 128
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 127
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 127
Totale 17.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.041 0 0 0 0 0 0 0 0 0 108 88 845
2021/20222.442 232 124 119 193 205 126 55 169 89 197 492 441
2022/20232.561 282 345 128 316 157 168 77 122 423 50 232 261
2023/20241.222 46 127 75 147 101 252 84 94 56 70 83 87
2024/20253.210 152 490 320 233 420 173 282 100 62 159 190 629
2025/20267.471 755 1.070 901 633 870 410 673 249 1.462 448 0 0
Totale 23.381